Exp Clin Endocrinol Diabetes 1990; 95(3): 307-314
DOI: 10.1055/s-0029-1210970
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Changes in β-Endorphin-Like-lmmunoreactivity in the Blood Plasma of Ewes during Estrous Cycle and in Anestrous Ewes under Stress Condition

A. Ostrowska, F. Przekop, B. Boguszewskí
  • Institute of Animal Physiology and Nutrition of Polish Academy of Sciences, Jablonna/ Poland
Further Information

Publication History

1989

Publication Date:
16 July 2009 (online)

Summary

In the light of evidence for endogenous opioid peptide involvement in the modulation of pituitary hormone release and in the body's overall response to stress, the aim of the present study was to determine the β-endorphin-like immunoreactivity (β-END-LI) in the blood plasma of ewes during different phases of the estrous cycle and in anestrous ewes subjected to acute or intermittent prolonged footshocks. The highest concentration of β-END-LI was found in the blood plasma during the luteal phase and lowest one during the follicular stage at proestrus. Nearly equal concentrations of β-END-LI were determined at estrus and metestrus ; their values were over 10 times lower than those observed in the luteal phase. Acute stress caused transient increase of β-END-LI in the blood plasma of anestrous ewes, with a peak after 15—30 min of footshock application and changes in the molar ratio of β-LPH to β-endorphin.

No apparent increase in mean daily levels of β-END-LI was noted in ewes subjected to prolonged footshocking ; however, on the day after stimulation β-END-LI concentration decreased below controll values. These results indicate that : 1. secretion of β-END-LI varies during different phases of the estrous cycle, 2. acute stress is a potent activator for β-END-LI secretion, 3. no apparent increase of β-END-LI in the blood plasma of ewes subjected to prolonged stress concomitant with accumulation of this material in pituitary (Polkowska and Przekop, 1988) supports the idea, that prolonged stress augments the synthesis of β-END-LI but not its release.